Arch Therapeutics Pink Sheet Forecast - Relative Strength Index
| ARTHDelisted Stock | USD 0.0001 0.00 0.00% |
Arch Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Arch Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The relative strength index (RSI) of Arch Therapeutics' share price is below 30 as of 29th of January 2026. This suggests that the pink sheet is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Arch Therapeutics, making its price go up or down. Momentum 20
Sell Stretched
Oversold | Overbought |
Using Arch Therapeutics hype-based prediction, you can estimate the value of Arch Therapeutics from the perspective of Arch Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Arch Therapeutics after-hype prediction price | USD 1.25E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Arch |
Arch Therapeutics Additional Predictive Modules
Most predictive techniques to examine Arch price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arch using various technical indicators. When you analyze Arch charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 20.43 | 20.43 |
| Check Arch Therapeutics Volatility | Backtest Arch Therapeutics | Information Ratio |
Arch Therapeutics Trading Date Momentum
| On January 29 2026 Arch Therapeutics was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 0.0. Lack of trading volume on January 29, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Arch Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arch Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Arch Therapeutics could also be used in its relative valuation, which is a method of valuing Arch Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Arch Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Arch Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arch Therapeutics shares will generate the highest return on investment. By undertsting and applying Arch Therapeutics pink sheet market strength indicators, traders can identify Arch Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 | |||
| Relative Strength Index | 20.43 |
Arch Therapeutics Risk Indicators
The analysis of Arch Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Arch Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arch pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 74.72 | |||
| Semi Deviation | 19.12 | |||
| Standard Deviation | 308.79 | |||
| Variance | 95348.55 | |||
| Downside Variance | 3936.1 | |||
| Semi Variance | 365.6 | |||
| Expected Short fall | (516.39) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Arch Therapeutics
The number of cover stories for Arch Therapeutics depends on current market conditions and Arch Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Arch Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Arch Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Arch Pink Sheet
If you are still planning to invest in Arch Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arch Therapeutics' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |